These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15659971)

  • 21. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
    Black S; Shinefield H; Baxter R; Austrian R; Bracken L; Hansen J; Lewis E; Fireman B
    Pediatr Infect Dis J; 2004 Jun; 23(6):485-9. PubMed ID: 15194827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pneumococcal conjugate vaccine (Prevnar; PNCRM7): a review of its use in the prevention of Streptococcus pneumoniae infection.
    Darkes MJ; Plosker GL
    Paediatr Drugs; 2002; 4(9):609-30. PubMed ID: 12175274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pneumococcal bacteremia in febrile infants presenting to the emergency department 8 years after the introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Mintegi S; Pocheville-Gurutzeta I; Sánchez Etxaniz J; Gómez Cortés B; Hernández Almaraz JL
    Pediatr Infect Dis J; 2010 Dec; 29(12):1142-4. PubMed ID: 20592642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance.
    Arifeen SE; Saha SK; Rahman S; Rahman KM; Rahman SM; Bari S; Naheed A; Mannan I; Seraji MH; Ahmed NU; Hassan MS; Huda N; Siddik AU; Quasem I; Islam M; Fatima K; Al-Emran H; Brooks WA; Baqui AH; Breiman RF; Sack D; Luby SP
    Clin Infect Dis; 2009 Mar; 48 Suppl 2():S103-13. PubMed ID: 19191605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Korea.
    Sohn HS; Suh DC; Jang E; Kwon JW
    J Manag Care Pharm; 2010; 16(1):32-45. PubMed ID: 20044845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
    Ingels HA
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.
    Kaplan SL; Mason EO; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ
    Pediatrics; 2004 Mar; 113(3 Pt 1):443-9. PubMed ID: 14993532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of the febrile child without a focus of infection in the era of universal pneumococcal immunization.
    Klein JO
    Pediatr Infect Dis J; 2002 Jun; 21(6):584-8; discussion 613-4. PubMed ID: 12182394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001-2006.
    Lepoutre A; Varon E; Georges S; Gutmann L; Lévy-Bruhl D
    Euro Surveill; 2008 Aug; 13(35):. PubMed ID: 18761883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine.
    Muñoz-Almagro C; Jordan I; Gene A; Latorre C; Garcia-Garcia JJ; Pallares R
    Clin Infect Dis; 2008 Jan; 46(2):174-82. PubMed ID: 18171247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review.
    Myint TT; Madhava H; Balmer P; Christopoulou D; Attal S; Menegas D; Sprenger R; Bonnet E
    Adv Ther; 2013 Feb; 30(2):127-51. PubMed ID: 23397399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.
    Ben-Shimol S; Givon-Lavi N; Grisaru-Soen G; Megged O; Greenberg D; Dagan R;
    Vaccine; 2018 Aug; 36(36):5477-5484. PubMed ID: 28579230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands.
    Bos JM; Rümke H; Welte R; Postma MJ
    Clin Ther; 2003 Oct; 25(10):2614-30. PubMed ID: 14667962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pneumococcal disease manifestation in children before and after vaccination: what's new?
    Andrade AL; Toscano CM; Minamisava R; Costa PS; Andrade JG
    Vaccine; 2011 Sep; 29 Suppl 3():C2-14. PubMed ID: 21896349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing epidemiology of outpatient bacteremia in 3- to 36-month-old children after the introduction of the heptavalent-conjugated pneumococcal vaccine.
    Herz AM; Greenhow TL; Alcantara J; Hansen J; Baxter RP; Black SB; Shinefield HR
    Pediatr Infect Dis J; 2006 Apr; 25(4):293-300. PubMed ID: 16567979
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in the Nature and Severity of Invasive Pneumococcal Disease in Children Before and After the Seven-valent and Thirteen-valent Pneumococcal Conjugate Vaccine Programs in Calgary, Canada.
    Ricketson LJ; Conradi NG; Vanderkooi OG; Kellner JD
    Pediatr Infect Dis J; 2018 Jan; 37(1):22-27. PubMed ID: 28737622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees.
    Dagan R; Sikuler-Cohen M; Zamir O; Janco J; Givon-Lavi N; Fraser D
    Pediatr Infect Dis J; 2001 Oct; 20(10):951-8. PubMed ID: 11642629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevenar experience.
    Arguedas A; Soley C; Abdelnour A
    Vaccine; 2011 Sep; 29 Suppl 3():C26-34. PubMed ID: 21896350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.